Tuesday, Jan 18, 2022
Focus on the big picture

Biogen's Alzheimer's Drug Coverage Limited by U.S.

Bloomberg, 12 Jan 2022
The U.S. government limited coverage of Biogen's Alzheimer's disease treatment and similar drugs through Medicare to patients ...
Related Articles